Published in Am J Clin Pathol on December 01, 2001
Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients. Am J Respir Crit Care Med (2012) 5.21
Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med (2012) 1.98
Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch (2003) 1.24
Myoepithelial Carcinoma: A Rare Neoplasm of the Breast. Breast Care (Basel) (2010) 1.04
The pivotal role of pathology in the management of lung cancer. J Thorac Dis (2013) 1.01
Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases. Virchows Arch (2005) 1.01
Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol (2012) 0.93
The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast. J Clin Pathol (2006) 0.93
The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung. PLoS One (2010) 0.92
p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol (2007) 0.90
The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung. Am J Pathol (2009) 0.88
Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev (2010) 0.86
Expression of p63 and p16 in primary and recurrent pterygia. Graefes Arch Clin Exp Ophthalmol (2006) 0.85
Synchronous bilateral epithelial-myoepithelial carcinoma of the parotid gland: case report and review of the literature. Eur Arch Otorhinolaryngol (2008) 0.85
Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping. Hum Pathol (2012) 0.85
Late-onset distant metastatic upper urinary tract urothelial carcinoma mimicking lung adenocarcinoma. Tuberc Respir Dis (Seoul) (2013) 0.85
Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder. J Histochem Cytochem (2011) 0.82
Neuropathology of brain metastases. Surg Neurol Int (2013) 0.82
A gene expression profile test to resolve head & neck squamous versus lung squamous cancers. Diagn Pathol (2013) 0.80
RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin. Neoplasia (2014) 0.80
Keratin 5 expression in squamocellular carcinoma of the head and neck. Oncol Lett (2014) 0.80
Squamous cell carcinoma in Barrett's esophagus: field effect versus metastasis. Dis Esophagus (2012) 0.80
Clear cell mesothelioma presenting as an incarcerated abdominal hernia. Virchows Arch (2005) 0.78
Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant basal-HER2 subtype of breast cancer. Oncotarget (2015) 0.78
Histopathology reporting of prostate needle biopsies. 2005 update. Virchows Arch (2006) 0.78
Expression of p63 and CK5/6 in early-stage lung squamous cell carcinoma is not only an early diagnostic indicator but also correlates with a good prognosis. Thorac Cancer (2015) 0.76
Hybrid model integrating immunohistochemistry and expression profiling for the classification of carcinomas of unknown primary site. J Mol Diagn (2010) 0.76
Paraneoplastic overlap syndrome in non-small squamous cell lung carcinoma. BMJ Case Rep (2014) 0.75
Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL. Oncotarget (2017) 0.75
Molecular pathological study of the human nasopharyngeal carcinoma CNE3 cell line. Oncol Lett (2013) 0.75
Splenic Metastasis from Cancer of Uterine Cervix-a Rare Case. Indian J Surg Oncol (2016) 0.75
Adequacy of endobronchial ultrasound-guided transbronchial needle aspiration samples processed as histopathological samples for genetic mutation analysis in lung adenocarcinoma. Mol Clin Oncol (2015) 0.75
Intraglomerular micrometastasis of squamous cell carcinoma. Clin Kidney J (2012) 0.75
Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma. Exp Hematol Oncol (2014) 0.75
Prognostic value of keratin subtyping in transitional cell carcinoma of the upper urinary tract. Virchows Arch (2004) 0.75
Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med (1997) 2.88
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer (2008) 2.67
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol (2004) 2.45
Acute right-sided heart failure due to hemorrhage into a pericardial cyst. Ann Thorac Surg (1997) 2.24
European and US publications in the 50 highest ranking pathology journals from 2000 to 2006. J Clin Pathol (2007) 2.20
Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J Clin Invest (1996) 2.00
Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res (1997) 1.89
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology (2000) 1.82
Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol (2001) 1.67
Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer (2000) 1.65
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis (1989) 1.64
Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet (1995) 1.63
Subcutaneous crystal-storing histiocytosis associated with lymphoplasmacytic lymphoma (immunocytoma) Pathol Res Pract (1996) 1.57
Cytomegalovirus reactivation and tumour necrosis factor. Lancet (1994) 1.55
CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer (2003) 1.49
Quality indicators in breast cancer care. Eur J Cancer (2010) 1.46
Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst (1999) 1.46
Telemicroscopy via the internet. Nature (1998) 1.44
Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer (1997) 1.44
Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol (2001) 1.43
[Inter-disciplinary European guidelines on surgery of severe obesity]. Vnitr Lek (2008) 1.42
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer (2008) 1.41
Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma. Br J Cancer (2004) 1.39
Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer (2000) 1.38
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer (2007) 1.37
Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology (2000) 1.36
Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart (1999) 1.33
Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis (1999) 1.30
Expression of AGR2 in non small cell lung cancer. Histol Histopathol (2007) 1.26
Prognostic factors for adenoid cystic carcinoma of the head and neck: a retrospective evaluation of 96 cases. J Oral Pathol Med (1990) 1.20
Genomic alterations associated with malignancy in head and neck cancer. Head Neck (1998) 1.17
Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol (2006) 1.17
A haemorrhagic fever from the Côte d'Ivoire. Lancet (1999) 1.17
Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology (1996) 1.16
Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer (1997) 1.16
Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res (1996) 1.14
[Her2 testing in gastric cancer. What is different in comparison to breast cancer?]. Pathologe (2010) 1.14
Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis (2000) 1.14
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study. Ann Oncol (2014) 1.13
The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene (2006) 1.13
Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12. Oncogene (1998) 1.10
Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res (1997) 1.09
Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst (1983) 1.08
Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma. Ann Hematol (2000) 1.07
Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod Pathol (1998) 1.07
Uterine tumor resembling ovarian sex-cord tumor--a case report and review of the literature. Virchows Arch (2001) 1.07
Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer. Histol Histopathol (2007) 1.07
In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin. J Natl Cancer Inst (1984) 1.06
Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines. Eur J Cancer (2000) 1.05
Cytomegalovirus infection and common variable immunodeficiency. Lancet (1992) 1.04
Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol (2000) 1.03
DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells. FEBS Lett (2001) 1.03
Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung. Oncogene (1998) 1.02
Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q. Br J Cancer (1998) 1.02
Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries. Virchows Arch A Pathol Anat Histopathol (1990) 1.01
A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma. Int J Gynecol Cancer (2008) 1.00
Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein. Biochem Pharmacol (1992) 1.00
[Necessity of increasing autopsy frequency following the introduction of DRGs]. Pathologe (2007) 0.99
[The UICC Telepathology Consultation Center. "Second opinion" over the Internet for pathologists]. Pathologe (2001) 0.99
Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers. Br J Cancer (2006) 0.97
Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. Hum Pathol (1997) 0.97
Personalized cancer medicine and the future of pathology. Virchows Arch (2011) 0.97
Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs. Int J Cancer (2000) 0.96
Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer. Eur J Cancer (2001) 0.96
Cancer beyond organ and tissue specificity: next-generation-sequencing gene mutation data reveal complex genetic similarities across major cancers. Int J Cancer (2014) 0.95
Influence of vitamin D3, 1,25-dihydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion, adenosine 3',5'-monophosphate release, and ultrastructure of parathyroid glands in organ culture. Endocrinology (1979) 0.94
Involvement of the DNA mismatch repair system in antineoplastic drug resistance. J Cancer Res Clin Oncol (1999) 0.94
Antigenicity testing by immunohistochemistry after tissue oxidation. J Clin Pathol (2007) 0.93
Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype. Br J Cancer (1998) 0.93
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. Br J Cancer (2010) 0.93
Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis. Br J Cancer (2005) 0.92
Genetic imbalances with impact on survival in colorectal cancer patients. Histopathology (2003) 0.92
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy. Ann Oncol (2012) 0.91
Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance. Br J Cancer (2000) 0.91
[Immunohistochemical diagnosis in cancer metastasis of unknown primary tumor]. Pathologe (2002) 0.91
Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome. Cancer (1997) 0.90
Cloning and characterization of human cDNAs encoding a protein with high homology to rat intestinal development protein OCI-5. Gene (1997) 0.90
Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera. J Cancer Res Clin Oncol (1986) 0.90
[Genetic screening of head-neck carcinomas using comparative genomic hybridization (CGH)]. Laryngorhinootologie (1996) 0.90
High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial. Radiother Oncol (1998) 0.88
[Study of efficiancy of teleconsultation: the Telepathology Consultation Service of the Professional Assoziation of German Pathologists for the screening program of breast carcinoma]. Verh Dtsch Ges Pathol (2005) 0.88
Image analysis for comparative genomic hybridization based on a karyotyping program for windows. Anal Quant Cytol Histol (1997) 0.88
Induction of transforming growth factor beta by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells. Am J Clin Oncol (1991) 0.88
Time gated fluorescence spectroscopy in Barrett's oesophagus. Gut (2003) 0.87
Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance. Int J Cancer (1999) 0.86
Immunohistochemical differentiation of metastases of renal carcinomas versus other carcinomas with anti-gamma GT monoclonal antibody 138H11. Histopathology (1997) 0.86
Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone. FEBS Lett (2001) 0.86
Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein. Int J Cancer (1997) 0.86
Actinomycotic inflammatory disease and misdiagnosis of ovarian cancer. A case report. Anticancer Res (2006) 0.86
Expression of aminopeptidase N/CD13 in human ovarian cancers. Int J Gynecol Cancer (2006) 0.86
Topoisomerase 1A, HER/2neu and Ki67 expression in paired primary and relapse ovarian cancer tissue samples. Histol Histopathol (2006) 0.85
Search for novel proteins involved in the development of chemoresistance in colorectal cancer and fibrosarcoma cells in vitro using two-dimensional electrophoresis, mass spectrometry and microsequencing. Electrophoresis (1999) 0.84
Specificity of PCR-based clonality analysis of immunoglobulin heavy chain gene rearrangements for the detection of bone marrow involvement by low-grade B-cell lymphomas. J Pathol (2000) 0.84
Paget's disease of the vulva with underlying apocrine adenocarcinoma and local lymph node invasion. Pathol Res Pract (1981) 0.84
Selection and characterization of a high-activity ribozyme directed against the antineoplastic drug resistance-associated ABC transporter BCRP/MXR/ABCG2. Cancer Gene Ther (2001) 0.84